Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

A Rare Case of CD1a + /CD207 + and S100 - Langerhans Cell Histiocytosis with Multi-System Risk Organ Involvement in Adult

Rishabh Singh, Priyanshu Nain, Saba Batool, Tulika Chatterjee, Mohammad Fahad B Asad, Manasa Kandula

Blood (2023) 142 (Supplement 1): 5364.

https://doi.org/10.1182/blood-2023-173587

Published: 2023

Journal Articles

Biallelic TET2 Inactivation in Myeloid Neoplasia: From Clonal Hierarchy to Clinical Phenotypes

Blood (2018) 132 (Supplement 1): 1805.

https://doi.org/10.1182/blood-2018-99-115154

Published: 2018

Journal Articles

Genotype-Resultant Morphology of Myelodysplastic Syndromes (MDS)

Abhinav Goyal, Inom Mirzaev, Mohammad Fahad B. Asad, Hassan Awada, MD, Cassandra M. Hirsch, Hideki Makishima, MD PhD, Kenichi Yoshida, MD PhD, Bartlomiej P. Przychodzen, Aziz Nazha, Sudipto Mukherjee, MD PhD MPH, Mikkael A. Sekeres, MD MS, Seishi Ogawa, MD PhD, Tomas Radivoyevitch, PhD, Jacob Scott, MD, Jaroslaw P. Maciejewski, Yasunobu Nagata

Blood (2018) 132 (Supplement 1): 1824.

https://doi.org/10.1182/blood-2018-99-119345

Published: 2018

Journal Articles

Heterozygous CTC1 Variants in Acquired Bone Marrow Failure

Wenyi Shen, MD, Cassandra M. Hirsch, Bartlomiej P. Przychodzen, Reda Z. Mahfouz, MD PhD, Tomas Radivoyevitch, Louis Williams, MD MBA, Mohammad Fahad B. Asad, Jaroslaw P. Maciejewski

Blood (2018) 132 (Supplement 1): 3866.

https://doi.org/10.1182/blood-2018-99-115193

Published: 2018

Journal Articles

Invariant Patterns of Clonal Succession Determines Specific Phenotypic and Clinical Features of Myelodysplastic Syndromes (MDS)

Blood (2018) 132 (Supplement 1): 104.

https://doi.org/10.1182/blood-2018-99-118861

Published: 2018

Journal Articles

Non-Random Interactions between Founder and Subclonal Mutations Shape the Clinical and Morphological Features of MDS

Blood (2017) 130 (Supplement 1): 583.

https://doi.org/10.1182/blood.V130.Suppl_1.583.583

Published: 2017

Journal Articles

BCOR Mutations in Myelodysplastic Syndromes (MDS): Mutation Characteristics Impact Clinical Outcomes

Nour Abuhadra, MD, Karam Al-Issa, MD, Sudipto Mukherjee, MD PhD MPH, Cassandra M. Hirsch, BS, Aaron T. Gerds, MDMS, Babal K Jha, PhD, Vera Adema, PhD, Hassan Awada, MD, Mohammad Fahad B Asad, MD MBBS, Abhinav Goyal, MD, Anjali S. Advani, MD, Yasunobu Nagata, MD PhD, Bartlomiej P. Przychodzen, MSc, Hetty E. Carraway, MD MBA, Jaroslaw P. Maciejewski, PhD MD FACP, Mikkael A. Sekeres, MD MS, Aziz Nazha, MD

Blood (2017) 130 (Supplement 1): 5304.

https://doi.org/10.1182/blood.V130.Suppl_1.5304.5304

Published: 2017

Journal Articles

Extent and Clinical Implications of Subclonal Diversity in Paroxysmal Nocturnal Hemoglobinuria

Mohammad Fahad B Asad, MD MBBS, Abhinav Goyal, MD, Hassan Awada, MD, Mai Aly, Cassandra Hirsch, Michael J. Clemente, Aziz Nazha, MD, Hetty E. Carraway, MD MBA, Sudipto Mukherjee, MD PhD MPH, Yasunobu Nagata, MD PhD, Jaroslaw P. Maciejewski, PhD MD FACP

Blood (2017) 130 (Supplement 1): 779.

https://doi.org/10.1182/blood.V130.Suppl_1.779.779

Published: 2017

Journal Articles

How Somatic Mutations Carve Morphologic Imprint in MDS?

Abhinav Goyal, MD, Mohammad Fahad B Asad, MD MBBS, Hassan Awada, MD, Mai Aly, MD, Cassandra M. Hirsch, BS, Bartlomiej P. Przychodzen, MSc, Tomas Radivoyevitch, PhD, Aziz Nazha, MD, Sudipto Mukherjee, MD PhD MPH, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, PhD MD FACP, Yasunobu Nagata, MD PhD

Blood (2017) 130 (Supplement 1): 2949.

https://doi.org/10.1182/blood.V130.Suppl_1.2949.2949

Published: 2017

Journal Articles

Model Heterogeneity in Predicting Outcomes of Patients with Myelodysplastic Syndromes (MDS)

Karam Al-Issa, MD, Yazan F. Madanat, MD, Sudipto Mukherjee, MD PhD MPH, Cassandra M. Hirsch, BS, Aaron T. Gerds, MDMS, Nour Abuhadra, MD, Ahed Makhoul, MD, Hassan Awada, MD, Mohammad Fahad B Asad, MD MBBS, Abhinav Goyal, MD, Anjali S. Advani, MD, Teodora Kuzmanovic, BA, Bartlomiej P. Przychodzen, MSc, Hetty E. Carraway, MD MBA, Jaroslaw P. Maciejewski, PhD MD FACP, Mikkael A. Sekeres, MD MS, Aziz Nazha, MD

Blood (2017) 130 (Supplement 1): 2972.

https://doi.org/10.1182/blood.V130.Suppl_1.2972.2972

Published: 2017

NARROW

A Rare Case of CD1a + /CD207 + and S100 - Langerhans Cell Histiocytosis with Multi-System Risk Organ Involvement in Adult

Biallelic TET2 Inactivation in Myeloid Neoplasia: From Clonal Hierarchy to Clinical Phenotypes

Genotype-Resultant Morphology of Myelodysplastic Syndromes (MDS)

Heterozygous CTC1 Variants in Acquired Bone Marrow Failure

Invariant Patterns of Clonal Succession Determines Specific Phenotypic and Clinical Features of Myelodysplastic Syndromes (MDS)

Non-Random Interactions between Founder and Subclonal Mutations Shape the Clinical and Morphological Features of MDS

BCOR Mutations in Myelodysplastic Syndromes (MDS): Mutation Characteristics Impact Clinical Outcomes

Extent and Clinical Implications of Subclonal Diversity in Paroxysmal Nocturnal Hemoglobinuria

How Somatic Mutations Carve Morphologic Imprint in MDS?

Model Heterogeneity in Predicting Outcomes of Patients with Myelodysplastic Syndromes (MDS)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only